T. Cain

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability

N. Patel, M. Jamei, A. Rostami-Hodjegan, 2014, Front. Pharmacol..

Bayesian inference for health state utilities using pairwise comparison data.

T. Cain, 2012 .

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling Within a Bayesian Framework to Identify Poor Metabolizers of Efavirenz (PM), Using a Test Dose of Efavirenz

M. Jamei, A. Rostami-Hodjegan, M. Chetty, 2018, Front. Pharmacol..

Estrogen Receptor Localization in Paraffin Sections By Enzyme Digestion, Repeated Applications of Primary Antibody, and Imidazole

J. Elias, T. Cain, A. Heimann, 1990 .

Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations

Khaled Abduljalil, Amin Rostami-Hodjegan, A. Rostami-Hodjegan, 2014, Drug Metabolism and Disposition.

Maintenance olaparib for patients with newly diagnosed, advanced ovarian cancer and a BRCA mutation: 5-year follow-up from SOLO1

A. Oza, M. Friedlander, Byoung-Gie Kim, 2021, Gynecologic Oncology.

A Tutorial on Pharmacodynamic Scripting Facility in Simcyp

K Abduljalil, D Edwards, A Barnett, 2016, CPT: pharmacometrics & systems pharmacology.

R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study

Rose Hart, Darren Burns, Bram Ramaekers, 2020, PharmacoEconomics.